WF
Insider
W. Michael Flanagan
Chief Scientific OfficerW. Michael Flanagan (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $473K of RNA (6,534 sh across 2 lots, as filed), executed Jan 21. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$645K
shares × price, as filed
Last traded
Jan 21
Filed Jan 23
Volume by month
Buys $0
Sells $4.4M
Shares × price, as filed · by filing month · past 24 months
Most traded names
RNA
RNA
0 buys · 9 sells
9 filings
Recent filings
RNASALE
Avidity Biosciences, Inc.
View filing →
$858K24,000 sh × $35.77
Exec Dec 11 2024
Filed Dec 13 2024 · 5:30 PM ET